Showing posts with label pharmaceutical sales models. Show all posts
Showing posts with label pharmaceutical sales models. Show all posts

Tuesday, April 10, 2012

The Double Dip - Deliver Impact and Flexibility with Tele-Sales Solutions

The sales function in life science companies continues to evolve and become more complex. The pressure to increase sales in a cost-effective manner grows by the day and sales executives are eagerly searching for innovative and impactful ways to grow sales.

Tele-sales programs are flexible programs that efficiently and effectively augment sales and promotional activities in many ways including…

1) Scheduling visits with a field-based representatives to provide 1-on-1 interaction when it’s needed

2) Expanding territories and coverage to ensure all healthcare providers in a given territory have regular interactions with company representatives

3) Supporting promotional programs for new indications and offers such as support groups or prescription rebates

4) Building relationships with office staff to provide a venue for answers to their questions and for requesting samples and educational materials

5) Providing responsive handling of scientific and/or clinical questions by healthcare-trained representatives when the caller wants and needs it
I recently recorded a Podcast through PharmaVOICE sharing insights we’ve gathered from tele-sales programs we’ve worked on for our clients. Also, we recently published a White Paper on this topic. The White Paper offers three case studies that demonstrate how tele-sales solutions can be customized to meet a number of promotional needs and audiences including physicians, their office staff, and patients and caregivers.

If you’d like to listen to the podcast titled “Insights from the Field: Tele-Sales Solutions”, please click here to download. Additionally, if you are interested in a copy of the white paper titled "Seize the Moment: Tele-Sales Solutions Delivering Impact and Flexibility", please click here to request it. Please let us know what you think of these two resources—are they helpful or not? Also, would you like to have additional resources in other areas? If so, please let us know what areas interest you.

View Full Blog  

View website for Tunstall AMAC Life Sciences 

Wednesday, April 4, 2012

Three Must-See Sessions at DTC Perspectives in April

The DTC Perspectives Conference starts next Tuesday, April 10 in Washington DC. The agenda looks great. I’m looking forward to hearing from executives at several life science companies on how they are changing their DTC programs to move away from brand promotion and awareness to focus on what patients need and want. When programs focus on what patients need and want we build engagement that can lead to commitment and loyalty.

There are three sessions that I’m particularly looking forward to...  

1) The New DTC: Using Technology to Build Relevance and Engagement with Paul Ewing and Todd Kolm at Pfizer. They are taking a case study approach to share insights into efforts to innovate consumer marketing at Pfizer.  

2) Effectively Reaching and Supporting Patients: A Novo Nordisk Case Study with Jeremy Shepler at Novo Nordisk and Rob Rebak at QualityHealth. They will be sharing key learnings from an integrated multichannel DTC program to drive educated doctor-patient interactions.  

3) Wake Up! Really, We Need to Wake Up! With Brian Lange at GSK. This presentation promises to help us recognize the cold hard reality that is in front of us each day, and will share tools to help us prepare for the next generation of DTC marketing initiatives.
I always look forward to learning from others, and the DTC Perspectives Conference is a great opportunity to engage with leaders that are boldly trying new things.

No doubt we live in exciting times. The opportunities to engage with patients and caregivers are rapidly changing, and the challenge is to develop patient programs that are meaningful and valuable. At PhoneScreen and AMAC we have been working with our life science company clients on a number of projects including tele-sales programs and patient support programs. These programs have the ability to quickly gather insights on the needs and challenges of patients, caregivers, and healthcare providers in managing a disease-state or condition. These insights enable our clients (and us) to develop meaningful programs.

If you are going to DTC Perspectives, please stop by our exhibit booth (look for the AMAC booth, which is number 29) and we’ll be happy to share with you how our programs can be customized to gather meaningful insights into what patients and caregivers need. If you would like to set up a time to meet at the DTC Perspectives meeting, please send me an e-mail and we’ll schedule a time to get together.

Hope to see you in Washington DC!

View Blog  

View website for Tunstall AMAC Life Sciences 

Thursday, March 8, 2012

New Options for Building Relationships with Healthcare Providers

Read a new article in PharmaVOICE magazine about new options for gaining access to physicians


In the last few weeks I’ve had numerous discussions with sales and marketing executives in life science companies about new ways to reach healthcare providers (particularly physicians) to build relationships and provide educational information on their products. This is always a topic of interest with our clients, but the frequency and intensity of these conversations has increased dramatically.

There is an article in the March 2012 issue of PharmaVOICE magazine (it’s available on-line now) that shares best practices on gaining access to physicians . The article shares findings on a study conducted by Temple University, and presented at the International Health Economic Association Congress in June 2011, on the ramifications of decreased access on new product uptake and prescribing. The findings provide evidence that patients are at greater risk when physicians are slow to prescribe beneficial new medications. Additionally, the majority of physicians feel that sales representatives are an important source of product information.

We all know very well the changes in how healthcare is delivered, including the emphasis on seeing more patients and limiting access to sales representatives. Now, with the Temple University study, we have data that supports what we also know is true, that sales representatives play a critical role in educating healthcare providers about new products. So, the important question is this…How do we deliver valuable education to healthcare providers within the reality of the physician’s office?

The PharmaVOICE article provides several recommendations, and the three listed below jumped out to me. They include…

1) Physician targeting—I prefer to think of this as segmentation, which is identifying healthcare providers that have a relationship with the company and/or brand and those that don’t. The healthcare providers that do have a relationship with the company and/or brand need on-going interactions with sales representatives. Healthcare providers that do not have an existing relationship with the company and/or brand need to be introduced to the company and/or brand and perhaps a relationship can be cultivated. With healthcare providers that don’t have an existing relationship there are several options including tele-detailing and e-detailing that can be effective in cultivating relationships with them.

2) Provide relevant information—this is commonly referred to as “providing value”, and “value” is uniquely personal to each individual. What is most needed is to understand the individual healthcare provider, their practice setting, the types of patients they treat, and the challenges they face in practice. To be successful a relationship must be established, and the sales representative must provide small “nuggets” of valuable information with each interaction.

3) Healthcare providers are becoming more comfortable seeking out information on their own. Commonly used secondary channels are product and company websites, tele-detailing, e-detailing, and mobile applications. The key take-away is to have multiple opportunities for healthcare providers to seek and gain information at their convenience and according to their own preferences.
There are a number of options that can be implemented to increase access to healthcare providers. At PhoneScreen and AMAC we provide pharmaceutical call center solutions that help you build relationships with patients, caregivers, and healthcare providers. Tele-detailing programs are an effective tool for providing information. Tele-detailing programs are complementary to field-based sales representatives and can be designed to provided 24/7 access to information and clinical expertise at the convenience of the healthcare provider.

Take a few minutes to review the PharmaVOICE article . After you read it, I’d like to hear your thoughts on it. Additionally, what new initiatives are you considering or implementing to expand healthcare provider access to product information and company representatives?

View Blog 

View website for Tunstall AMAC Life Sciences

Wednesday, February 1, 2012

24/7 The New Norm: HCPs Require Instant Access to Reps and Information

Read a new article in PharmaVOICE magazine about how call centers provide a vital link for HCPs and life science companies

The February 2012 issue of PharmaVOICE magazine is available on-line. In the Showcase Feature section they discuss outsourcing R&D, manufacturing, and sales functions to 3rd-parties to reduce in-house costs and accelerate timelines. I contributed a brief article on how pharmaceutical call centers build relationships with healthcare providers and patients. The primary benefit of a call center is to provide on-demand and as-needed access to information and company representatives on a 24/7 basis.

Pharmaceutical call centers can support the life science industry to…
• Provide on-demand support to answer questions from healthcare providers and patients
• Increase patient adherence to treatments and clinical trials
• Supplement field-based promotional activities
• Boost patient recruitment and referral for clinical trials
• Process sample requests
• Set appointments between sales representatives and healthcare providers

Download the PharmaVOICE article. After you read it, I’d like to hear your thoughts on it. Also, are you currently using partners to outsource your information and sales activities? If so, in what areas are you doing this? What challenges and hurdles have you run into? Are you happy with the results you’ve seen?

View Blog 

View website for Tunstall AMAC Life Sciences 

Tuesday, January 10, 2012

Adding Value to Your Pharma Sales Model

Several of my early blog posts focused on the value of tele-detailing in providing information to healthcare providers. With all of the pressures on the industry we must find new, more cost-effective channels for communicating with healthcare providers. Tele-detailing is an effective promotional channel, and it complements the daily activities of field-based representatives.

Physicians and healthcare providers are demanding valuable interactions with company representatives. One channel for providing valuable interactions to physicians is through tele-detailing programs. These programs provide physicians and healthcare providers with an efficient and knowledgeable means to learn about pharmaceutical, biotech, and medical device products and to obtain answers to their questions at their convenience. In November 2010, Cegedim published a report on the promotional spending trends in new media (including tele-detailing, internet detailing, and web advertising) from US pharmaceutical companies. They found that 49% of the spending in new media is on tele-detailing programs.

I recently recorded a podcast through PharmaVOICE on how tele-detailing can help pharmaceutical, biotech, and medical device companies provide value to healthcare providers. Also, we recently published a white paper on this topic. The White Paper offers suggestions for how tele-detailing programs augment and complement the activities of sales representatives, how to determine if tele-detailing is right for your product, and how to shift the role of sales representatives from salesperson to an “Advisor.”

Please let us know what you think of the podcast and white paper — are they helpful or not? Also, would you like to have additional resources in other areas? If so, please let us know what areas interest you.

View Blog  

View website for Tunstall AMAC Life Sciences 

Tuesday, October 18, 2011

Is Tele-detailing Right for Your Product?




Lou Shapiro

I often get asked if tele-detailing can help a specific product in pharma. The answer is not always a resounding "yes" or a simple "no."




Have you considered tele-detailing to support your pharmaceutical product(s)? The most obvious application of tele-detailing is to cover vacant sales territories. However, in my experience tele-detailing can be an effective tool in a number of situations including:

• Products that are under-resourced with sales reps. Tele-detailing representatives can provide product information, answer questions, and process and fulfill sample requests

• An established product facing increased competition from new entrants. Healthcare-trained representatives (ie, RNs and pharmacists) can answer clinical and scientific questions from physicians

• A new product entering a marketplace with entrenched market leaders. Tele-detailing representatives can provide additional promotional support to “early adopters”, as well as answer questions and fulfill sample requests

• An established product that is profitable, but gets little detailing time from sales reps. Tele-detailing representatives can call on top-prescribing physicians to share new data on the product, or mid-tier prescribing physicians to remind them of the product’s efficacy, safety, and ease of use

Tele-detailing is an effective, flexible and efficient promotional tool. I’ll share the essential elements of a successful tele-detailing program in a future blog posting.

In the mean time, download a copy of our latest whitepaper, “Selecting the Right Call Center Partner: Tips for Success.” (http://bit.ly/pscallcenter)

We also did a recent podcast with PharmaVOICE entitled "Keys to Partnering with a Pharmaceutical Call Center" (http://bit.ly/ps092011podcast) which you should check out if you are interested in more on this topic.

Have you used tele-detailing to support your pharmaceutical product(s)? If so, what results did you see? Have you decreased, maintained or increased your tele-detailing efforts? I’d like to hear about your experiences with tele-detailing. Please share your thoughts in the comments of this blog post.

View Blog

Thursday, August 11, 2011

Pharma’s Shifting Sales Model: How Tele-detailing Can Add Value



Lou Shapiro

We all know first-hand the changes the pharmaceutical and healthcare industries are undergoing. The factors impacting these changes span the gamut from fewer blockbuster products, shifts to specialized therapies, increased drug development costs, and increased reimbursement pressures and uncertainties. Certainly we are all feeling the push to do more with less.



Add to these challenges that physicians are busier than ever, and are adopting “no see” policies for sales representatives. And, the inevitable conclusion is that sales models that pharmaceutical and biotechnology companies have used for years must change.

Sales models are adapting to include new “channels”, such as tele-detailing, e-detailing, and web advertising to physicians. The primary channel to date has been live in-office interaction with a sales representative. What are needed are complementary secondary channels that are available 24/7 and on-demand. One such option is 24/7 on-demand tele-detailing to healthcare providers. The benefit of tele-detailing is that it is available at the healthcare providers’ convenience to answer product questions, provide information, and process and ship requests for samples. Additionally, tele-detailing representatives can immediately transfer callers with scientific and clinical questions to healthcare-trained representatives.

The industry is investing more in tele-detailing. In a report published in November 2010, Cegedim looked at promotional spending trends in new media. Their research found that pharmaceutical companies spent $327M in new media between October 2009 and September 2010. Of the $327M, 49%, or $160M, was spent on tele-detailing. This was more than on the other new media options including internet detailing, e-meetings, and web advertising to physicians.

In my experience, physicians’ value interactions that are consultative, and they don’t want to be “sold to”. Sales representatives need to shift their mindset from the role as a “salesman” to an “advisor”. Attributes of an advisor include…

• Continually acquiring scientific and pharmacoeconomic knowledge. In particular be able to communicate the value of your product

• Understand regulatory and compliance issues physician’s offices are facing

• Most importantly, be focused on the physician’s needs rather than the features and benefits of your product

• Nurture relationships with physicians. Take the time to understand individual physicians’ unique needs and provide appropriate solutions. Also, pay attention to timely follow up and deliver materials that have been requested

Over the years I have worked with many pharmaceutical and biotechnology companies to develop and implement customized tele-detailing programs that support the important work sales representatives do each day. At Phone Screen we provide live operator support to answer questions at a physician’s convenience, and we can also place “outbound” calls to physicians’ offices to provide a tele-detail on a product or to process sample requests.

Are your sales efforts less effective today? Are there particular challenges you face in developing consultative relationships with healthcare providers? Perhaps you have best practices to share in these areas. Please join the conversation and share your questions, challenges and best practices.

Visit the PhoneScreen Website at www.phonescreen.com



View Blog